Effects of Pregnancy for Cystic Fibrosis Patients

Trial Objectives

A national research study called MAYFLOWERS wants to understand the changes of lung function in pregnant women with cystic fibrosis (CF) during pregnancy and 2 years after delivery. It also looks at the health of their babies. Additionally, if women are taking any Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator, including TRIKAFTA®, the study will look at the effect of modulator on the health of mother and baby.

Who Can Participate

Pregnant women with cystic fibrosis.

Age: 16+ Gender Any

Estimated Time Commitment

7 to 9 clinic visits

Time Commitment Details

Up to three visits during pregnancy and up to six visits over the two years after delivery.

Payment & Reimbursement

Payment Provided

Travel Reimbursement Available

Trial Contact

For more information, contact:

Salma Moreno
303-270-2681

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

TDN

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

First Name

Last Name

Email Address

Phone

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health

Yes